Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis

PharmacoEconomics

Volumn 9, Issue 6, 1996, Pages 497-505

  Fong, Ignatius W ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ASTEMIZOLE; BUTOCONAZOLE; CISAPRIDE; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MONISTAT 3; MONISTAT 7; NIZONAL; NON PRESCRIPTION DRUG; NYSTATIN; PYRROLE DERIVATIVE; TERAZOL 3; TERAZOL 7; TERCONAZOLE; TERFENADINE; TIOCONAZOLE; UNCLASSIFIED DRUG;

ANAPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; CREAM; DRUG CAPSULE; DRUG COST; DRUG EFFICACY; ECONOMIC ASPECT; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HEALTH CARE SYSTEM; HUMAN; INFLUENZA; INTRAVAGINAL DRUG ADMINISTRATION; OINTMENT; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; PHARMACOECONOMICS; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; REVIEW; TABLET; URTICARIA; VAGINA CANDIDIASIS; VULVOVAGINITIS;

EID: 0029955310     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199609060-00004     Document Type: Review

References (42)

1. Centers for Disease Control. Non-reported sexually transmitted diseases. Morb Mortal Wkly Rep 1979; 28: 61
2. Hurley R, DeLouvois J. Candida vaginitis. Postgrad Med J 1979; 55: 645-7
3. Hurley R. Recurrent Candida infection. Clin Obstet Gynecol 1981; 8: 209-13
4. Sobel JD. Genital candidiasis. In: Bodey PD, editor. Candidiasis: pathogenesis, diagnosis and treatment. 2nd ed. New York: Raven Press, 1991: 225-47
5. Annual Reports of Chief Medical Officer, Department of Health and Social Services, 1976-1984 (England and Wales)
6. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165: 1168-76
7. Fleury FJ. Adult vaginitis. Clin Obstet Gynecol 1981; 24: 407-38
8. Odds FC. Candidosis of the genitalia. In: Odds FC, editor. Candida and candidosis. 2nd ed. London: Bailliere Tindall. 1988: 124-35
9. Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynetol 1993; 36: 153-65
10. Sobel JD, Schmitt C, Merriwether C. A new slide latex agglutination test in diagnosis of Candida vaginitis. Am J Clin Pathol 1990; 94: 323-5
11. Fong IW, McCleary P, Read S. The cellular immunity of women with chronic recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1992; 166: 887-90
12. Doering PL, Santiago TM. Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens. DICP Ann Pharmacother 1990; 24: 1078-83
13. Topical drugs for vaginal candidiasis. Med Lett Drugs Ther 1991; 33 (851): 81
14. Isaacs JH. Nystatin vaginal cream in monilial vaginitis. Int Med J 1973; 143: 240-1
15. Corson SL, Kapikian RR, Nehring R. Terconazole and miconazole cream for treating vulvovaginal candidiasis: a comparison. J Reprod Med 1991; 36: 561-7
16. Tooley PJ. Patient and doctor preferences in the treatment of vaginal candidiasis. Practitioner 1985; 229: 655-60
17. Reed BD, Eyler A. Vaginal infections: diagnosis and management. Am Fam Physician 1993; 47: 1805-16
18. Oral fluconazole for vaginal candidiasis. Med Lett Drugs Ther 1994; 36 (931): 81-2
19. Phillips RJM, Watson SA, McKay FF. An open multicentre study of the efficacy and safety of a single dose of fluconazole 150mg in the treatment of vaginal candidiasis in general practice. Br J Clin Pract 1990; 44: 219-22
20. Neuhaus G, Pavic N, Pletscher M. Anaphylactic reaction after oral fluconazole [letter]. BMJ 1991; 302: 1341
21. Sobel JD. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol 1985; 65: 435-50
22. Sanz Sanz F, del Palacio-Hermanz A. Random comparative trial of three regimens of itraconazole for treatment of vaginal mycoses. Rev Infect Dis 1987; 9 Suppl. I: S139-42
23. Cauwenberg G, Vanden Bossche H. Terconazole: pharmacology of a new antimycotic agent. J Reprod Med 1989; 34 (8 Suppl.): 588-92
24. Lewis JH, Zimmerman HJ, Benson GD, et al. Hepatic injury associated with ketoconazole therapy: analysis of 33 cases. Gastroenterology 1984; 86: 503-13
25. Monahan BP, Ferguson CL, Kelleavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990 Dec; 264 (21): 2788-90
26. Crane JK, Shih H-T. Syncope and cardiac arrythmia due to an interaction between itraconazole and terfenadine. Am J Med 1993; 95: 455-6
27. Ahmad SR, Wolfe SM. Cisapride and torsades de pointes [letter]. Lancet 1995; 345: 508
28. Segal M. Rx to OTC: the switch is on. FDA Consumer 1991 Mar: 9-11
29. Schaaf VM, Perez-Stable EJ, Borechardt K. The limited value of symptoms and signs in the diagnosis of vaginal infections. Arch Intern Med 1990; 150: 1929-33
30. Taylor CA, Lipsky MS. Physicians' perception of the impact of the reclassification of vaginal antifungal agents. J Fam Pract 1994; 38: 157-60
31. Hilton E, Isenberg EH, Alperstein P, et al. Ingestion of yogurt containing lactobacillus. Ann Intern Med 1992; 116: 353-7
32. Fong IW. The value of treating sexual partners of women with recurrent vaginal candidiasis with ketoconazole. Genitourin Med 1992; 68: 174-6
33. Fong IW, Bannatyne RM, Wong P. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin Med 1993; 69: 44-6
34. Davison F, Mould RF. Recurrent genital candidiosis with intermittent prophylactic treatment. Br J Vener Dis 1978; 54: 176-83
35. Sobel JD, Schmitt C, Merriwether C. Clotrimazole treatment of recurrent and chronic Candida vulvovaginitis. Obstet Gynecol 1989; 73: 330-4
36. Sobel JD. Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. Int J Gynecol Obstet 1992; 37 Suppl. 1: 17-24
37. Creatsas GC, Charalambidis VM, Zagotzidou EH, et al. Chronic or recurrent vaginal candidiosis: short-term treatment and prophylaxis with itraconazole. Clin Ther 1993; 15: 662-71
38. Fong IW. The value of prophylactic (monthly) clotrimazole versus empiric self-treatment in recurrent vaginal candidiasis. Genitourin Med 1994; 70: 124-6
39. Sobel JD. Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986; 315: 1455-8
40. Fong IW. The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis. Genitourin Med 1992; 68: 374-7
41. Morton O. Neotran: a new double-active pessary for the treatment of vaginitis. J Int Med Res 1993; 21: 36-46
42. McCue JD. Evaluation and management of vaginitis: an update for primary care practitioners. Arch Intern Med 1989; 149: 565-8